Stock listing
IPHA Stock Price, News, Filings & Events — Innate Pharma Sa Class A
Selected listing: IPHA · NASDAQ · USD · US
This page tracks Innate Pharma Sa Class A's IPHA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPHA:NASDAQ. IPHA:NASDAQ is the stock-level entry point for investors researching Innate Pharma Sa Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- IPHA:NASDAQ
- Asset type
- Stock
- Market cap
- $206.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Innate Pharma Sa Class A IPHA:NASDAQ stock context
This page tracks Innate Pharma Sa Class A's IPHA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IPHA:NASDAQ. IPHA:NASDAQ is the stock-level entry point for investors researching Innate Pharma Sa Class A, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Innate Pharma Sa Class A
Innate Pharma to Host Conference Call and Webcast on September 17 for First Half 2026 Financial Results and Business Update
September 10, 2026
Innate Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Innate Pharma : Announces Pricing of €30 million Offering of Ordinary Shares
August 14, 2026
Innate Pharma Announces Proposed Offering of Ordinary Shares
August 13, 2026
Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
August 10, 2026
Innate Pharma Sa Class A earnings calls
Innate Pharma S.A. (IPHA) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Innate Pharma S.A. (IPHA) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Innate Pharma S.A. (IPHA) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Innate Pharma S.A. (IPHA) Q2 2025 Earnings Call
September 17, 2025 · Replay with transcript and chapters
Innate Pharma S.A. (IPHA) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Innate Pharma S.A. (IPHA) Q4 2024 Earnings Call
March 27, 2025 · Replay with transcript and chapters
Research Innate Pharma Sa Class A
Innate Pharma Sa Class A investor report
Review AI stock analysis and investor report context for IPHA:NASDAQ.
Innate Pharma Sa Class A company profile
View the public company page for Innate Pharma Sa Class A on 6ix.
Innate Pharma Sa Class A news
Read company news and market updates connected to Innate Pharma Sa Class A.
Innate Pharma Sa Class A investor events
Find investor webinars, events, and replay context for Innate Pharma Sa Class A.
Alternate listings
IPH:EURONEXT
FR · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IDD:GETTEX
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
4IPH:EUROTLX
IT · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IPHYF:OTC
US · USD
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
0EVI:LSIN
GB · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
A0LCUJ:LSX
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IPHP:AQUISEU
GB · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
A0LCUJ:LS
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IPHP:AQUISUK
GB · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IDD:SWB
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IDD:XETR
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.
IDD:TRADEGATE
DE · EUR
Alternate listing for Innate Pharma Sa Class A; the primary context on this page is IPHA:NASDAQ.